OptiNose
NASDAQ: OPTN
Healthcare
Drug Manufacturers - Specialty & Generic
Rank
#24082
Market Cap
98.39 M
Volume
169,859
Price
9.72
Change (%)
2.05%
Country or region
United States
United States
OptiNose's latest marketcap:
98.39 M
As of 05/16/2025, OptiNose's market capitalization has reached $98.39 M. According to our data, OptiNose is the 24082th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 98.39 M |
| Revenue (ttm) | 81.86 M |
| Net Income (ttm) | -29,890,000 |
| Shares Out | 10.13 M |
| EPS (ttm) | -2.67 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 05/27/2025 |
Market Cap Chart
Data Updated: 05/16/2025
OptiNose's yearly market capitalization.
OptiNose has seen its market value drop from $215.61 M to $98.39 M since 2020, representing a total decrease of 54.37% and an annual compound decline rate (CAGR) of 16.42%.
| Date | Market Cap | Change (%) |
|---|---|---|
| 05/16/2025 | $98.39 M | 41.58% |
| 12/31/2024 | $67.17 M | -53.64% |
| 12/29/2023 | $144.88 M | -28.7% |
| 12/30/2022 | $203.20 M | 52.6% |
| 12/31/2021 | $133.16 M | -38.24% |
| 12/31/2020 | $215.61 M |
Company Profile
Frequently Asked Questions
As of 05/16/2025, OptiNose (including the parent company, if applicable) has an estimated market capitalization of $98.39 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
OptiNose global market capitalization ranking is approximately 24082 as of 05/16/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.
Stock Detail
| Country or region | United States |
| Founded | 2010 |
| IPO Date | 10/13/2017 |
| Employees | 128 |
| CEO | |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Address | |
| Website |
